Vergoeding 2020-2024 per ATC-hoofdgroep C : Hartvaatstelsel
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| C01 Cardiaca | 24.965.300 | 23.935.700 | 26.930.100 | 26.058.700 | 27.943.700 |
| C02 Antihypertensiva | 39.273.600 | 36.875.600 | 40.506.000 | 43.890.200 | 44.151.500 |
| C03 Diuretica | 24.572.400 | 26.771.900 | 27.935.500 | 28.697.700 | 32.115.000 |
| C04 Perifere vasodilatantia | 105.800 | 97.208 | 86.807 | 83.324 | 78.358 |
| C05 Vasoprotectiva | 1.023.900 | 1.265.500 | 1.403.600 | 1.646.500 | 1.897.500 |
| C07 Beta-blokkers | 28.596.600 | 33.901.500 | 35.694.600 | 38.092.900 | 43.708.900 |
| C08 Calciumantagonisten | 37.813.800 | 39.201.100 | 41.233.500 | 45.847.500 | 51.691.800 |
| C09 Middelen aangrijpend op het renine-angiotensinesysteem | 69.289.100 | 77.033.800 | 98.435.000 | 113.909.700 | 132.963.500 |
| C10 Antilipaemica | 139.950.000 | 148.811.900 | 175.529.600 | 195.203.700 | 222.089.100 |
| Totaal | 365.590.500 | 387.894.208 | 447.754.707 | 493.430.224 | 556.639.358 |